BridgeBio Pharma, Inc. (BBIO) Operating cash flow 2017–2025
BridgeBio Pharma, Inc. (BBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$445.9MFY2025 · since FY2017: -$40.5M → -$445.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$445.9M | +14.4% |
| FY2024 | -$520.7M | +1.3% |
| FY2023 | -$527.7M | -25.8% |
| FY2022 | -$419.5M | +15.8% |
| FY2021 | -$497.9M | -24.6% |
| FY2020 | -$399.7M | -57.6% |
| FY2019 | -$253.6M | -85.6% |
| FY2018 | -$136.6M | -237.5% |
| FY2017 | -$40.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice